Twist Bioscience Corporation TWST
$ 47.6
9.12%
Annual report 2024
added 11-18-2024
Twist Bioscience Corporation Balance Sheet 2011-2024 | TWST
Annual Balance Sheet Twist Bioscience Corporation
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-141 M | -192 M | -285 M | -406 M | -86.4 M | -39 M | -71 M | -22.1 M | -17.4 M | - | - | - | - | - |
Long Term Debt |
70.2 M | 79.2 M | 81.3 M | 53.2 M | 1.4 M | 4.4 M | 7.22 M | 9.15 M | 9.81 M | - | - | - | - | - |
Long Term Debt Current |
14.8 M | 14.9 M | 13.6 M | 8.21 M | 6.41 M | 3.33 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 4.56 M | 299 M | 210 M | 144 M | - | - | - | - | - |
Total Current Liabilities |
71 M | 73.3 M | 90.7 M | 63.1 M | 36 M | 30.4 M | - | - | - | - | - | - | - | - |
Total Liabilities |
142 M | 153 M | 172 M | 121 M | 62.6 M | 34.9 M | 317 M | 219 M | 153 M | - | - | - | - | - |
Deferred Revenue |
2.13 M | 3 M | 3.48 M | 1.09 M | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.24 B | -1.03 B | -828 M | -611 M | -458 M | -319 M | -211 M | -140 M | -80.3 M | - | - | - | - | - |
Total Assets |
614 M | 776 M | 961 M | 702 M | 399 M | 187 M | 116 M | 85.7 M | 76.5 M | - | - | - | - | - |
Cash and Cash Equivalents |
226 M | 286 M | 380 M | 467 M | 94.2 M | 46.7 M | 80.8 M | 31.6 M | - | - | - | - | - | - |
Book Value |
473 M | 623 M | 789 M | 581 M | 336 M | 152 M | -201 M | -133 M | -76.6 M | - | - | - | - | - |
Total Shareholders Equity |
473 M | 623 M | 789 M | 581 M | 336 M | 152 M | -201 M | -133 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Twist Bioscience Corporation
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
72.6 M | 74.8 M | 77.1 M | 79.2 M | 79.9 M | 77.8 M | 79.7 M | 81.3 M | 64.2 M | 65.5 M | 60.3 M | 53.2 M | 53.8 M | 53.2 M | 625 K | 1.4 M | 1.4 M | 1.4 M | 3.67 M | 4.4 M | 4.4 M | 4.4 M | 6.53 M | 7.22 M | 7.22 M | 7.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
147 M | 143 M | 143 M | 153 M | 153 M | 150 M | 164 M | 172 M | 159 M | 158 M | 160 M | 121 M | 115 M | 121 M | 61.6 M | 62.6 M | 62.6 M | 62.6 M | 89.2 M | 34.9 M | 34.9 M | 34.9 M | 25.9 M | 26.7 M | 26.7 M | 26.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
2.94 M | 2.54 M | 2.64 M | 3 M | 3 M | 1.94 M | 3.68 M | 3.48 M | - | - | - | - | - | 600 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.21 B | -1.12 B | -1.08 B | -1.03 B | -987 M | -929 M | -870 M | -828 M | -777 M | -717 M | -656 M | -611 M | -569 M | -611 M | -491 M | -458 M | -458 M | -458 M | -374 M | -319 M | -319 M | -319 M | -233 M | -211 M | -211 M | -211 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
638 M | 703 M | 733 M | 776 M | 810 M | 854 M | 910 M | 961 M | 980 M | 1.02 B | 786 M | 702 M | 725 M | 702 M | 700 M | 399 M | 399 M | 399 M | 192 M | 187 M | 187 M | 187 M | 164 M | 116 M | 116 M | 116 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
239 M | 243 M | 266 M | 286 M | 312 M | 318 M | 319 M | 379 M | 378 M | 409 M | 193 M | 466 M | 477 M | 466 M | 349 M | 94.2 M | 93.7 M | 93.7 M | 26 M | 46.7 M | 46.7 M | 46.7 M | 66.5 M | 80.8 M | 80.8 M | 80.8 M | 26.3 M | 31.2 M | - | - | - | 29.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
491 M | 560 M | 590 M | 623 M | 658 M | 704 M | 746 M | 789 M | 821 M | 863 M | 626 M | 581 M | 610 M | 581 M | 638 M | 336 M | 336 M | 336 M | 103 M | 152 M | 152 M | 152 M | 139 M | 89.1 M | 89.1 M | 89.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
491 M | 560 M | 590 M | 623 M | 658 M | 704 M | 746 M | 789 M | 821 M | 863 M | 626 M | 581 M | 610 M | 614 M | 638 M | 336 M | 638 M | 638 M | 103 M | 152 M | 103 M | 103 M | 139 M | -201 M | 139 M | 139 M | -150 M | -133 M | - | - | - | -76.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency